NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
July 30, 2026 — Onco-Innovations closes CAD$5M private placement with Sorbie to fund ONC010 program and SynoGraph platform for solid tumour therapies. Learn about the financing and its impact.
July 30, 2026 — Earth Science Tech (ETST) reports 8% revenue growth driven by its vertically integrated healthcare model combining telemedicine, compounding pharmacies, and fulfillment. Learn how ETST is transforming patient care.
July 30, 2026 — Nancy Brown, CEO of American Heart Association, named to NonProfit Times Power and Influence Top 50 for 11th time, celebrating 40 years of service and leadership in cardiovascular health.
July 30, 2026 — Dr. Lee Newcomer signs with Creative Management Partners for his book UNMASKED, sharing insights from both sides of the hospital bed. Learn about this health care expert's story.
July 30, 2026 — New study shows vitamin B12 therapy could halt glioblastoma multiforme (GBM) progression. CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is among companies advancing brain cancer treatments. Read more on BioMedWire.
July 30, 2026 — VolitionRx Limited highlights growing evidence for its Nu.Q NETs assay as a sepsis biomarker. The test distinguishes sepsis from inflammation and predicts outcomes. Learn how this low-cost blood test could personalize patient care.
July 30, 2026 — SS Innovations International expands its global footprint with the SSi Mantra robotic surgery platform, focusing on affordability, training, and over 12,000 procedures across 170 indications.
July 30, 2026 — HeartBeam (NASDAQ: BEAT) to host Q2 2026 earnings call on Aug 13, updates on ambulatory ECG platform. FDA-cleared 3D ECG technology aims to transform cardiac care.
July 30, 2026 — Instinct Bio partners with Invitrx to launch GENREVER cosmetics in the U.S. and advance regenerative medicine in Indonesia, leveraging Japanese innovation and U.S. GMP manufacturing.
July 30, 2026 — Learn immediate steps after a car accident from Goldstein & Goldstein, LLP. Protect your rights, document evidence, and avoid insurance pitfalls in New Jersey.
July 30, 2026 — Chelsea Elizabeth returns to HCA Florida Blake Hospital for reconstructive surgery after a dog attack. Her story reveals the invisible realities of long-term trauma recovery, identity loss, and rebuilding life. Learn about The Life Rewritten Trilogy and Restore180 Foundation.
July 30, 2026 — Dr. Alexandre B. de Moura and Dr. Timothy T. Roberts of New York Spine Institute are named 2026 Castle Connolly Top Doctors, a peer-selected honor for only 7% of US physicians.
July 30, 2026 — Learn how to get affordable dental implants with expert tips on cost factors, financing, and choosing the right dentist. Save money without compromising quality.
July 29, 2026 — Regentis Biomaterials (RGNT) advances Gelrin C hydrogel for knee cartilage repair, targeting 470,000 annual procedures and $3B market. Learn about its single-stage, cell-free treatment for osteoarthritis.
July 29, 2026 — VERAXA Biotech expands IP portfolio with new patent filings covering BiTAC-TCE and BiTAC-ADC platforms. Learn how this strengthens its next-generation cancer therapy pipeline.
July 29, 2026 — MindBio Therapeutics delivers first Edge AI Intoxication and Fatigue Detection Kiosk prototypes using voice analysis for workplace safety. Targeting mining, aviation, construction, and law enforcement.
July 29, 2026 — NeuroThera Labs validates quantum sampling workflow for clinical data analytics, using hybrid quantum-classical computing to represent continuous probability distributions. This breakthrough could transform drug development and biomedical research.
July 29, 2026 — Datavault AI expands licensing with DataMeds to extend PharmacyChain blockchain into healthcare, enabling patient-controlled data access and monetization. Learn about the $19.9% stake and AI-driven health solutions.
July 29, 2026 — VERAXA Biotech appoints Dr. Christoph Erkel as CSO to lead BiTAC(R) platform development. Learn about the company's oncology pipeline and next-generation immunotherapies.
July 29, 2026 — VERAXA Biotech (NASDAQ: VRXA) expands IP portfolio with new patent filings for BiTAC-TCE and BiTAC-ADC platforms, protecting technologies through 2047. Learn how this strengthens its oncology pipeline.